Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health

Psychiatric Genetics

Volumn 15, Issue 2, 2005, Pages 109-115

  Olsson, Craig A ^a,b   Anney, Richard J L ^a   Lotfi Miri, Mehrnoush ^a   Byrnes, Graham B ^a   Williamson, Robert ^a   Patton, George C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Adolescent; Anxiety; Catechol O methyltransferase; Depression; Longitudinal design; Neuroticism; Population sample

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADOLESCENT; ALLELE; ANXIETY DISORDER; ARTICLE; AUSTRALIA; AVOIDANCE BEHAVIOR; DISTRESS SYNDROME; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENERALIZED ANXIETY DISORDER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PANIC; PHOBIA; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; ADULT; AMINO ACID SUBSTITUTION; ANXIETY; CHILD HEALTH CARE; COHORT ANALYSIS; GENETICS; HETEROZYGOTE DETECTION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; AMINO ACID SUBSTITUTION; ANXIETY; AUSTRALIA; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LONGITUDINAL STUDIES; MALE; METHIONINE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE;

EID: 20444383849     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200506000-00007     Document Type: Article

References (27)

1. Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP (2003). Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am J Psychiatry 160:671-676.
2. Costa PT, McCrae RR (1989). The NEO/FFI manual supplement. Odessa, Florida: Psychological Assessment Resources.
3. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE (2001). Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
4. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003). Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13:33-41.
5. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
6. Grossman MH, Emanuel BS, Budarf ML (1992). Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 12:822-825.
7. Hamilton SP, Slager SL, Heiman GA, Deng Z, Haghighi F, Klein DF, et al. (2002). Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychaitry 51:591-601.
8. Henderson AS, Korten AE, Jorm AF, Jacomb PA, Christensen H, Rogers B, et al. (2000). COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am J Med Genet 96:102-107.
9. Jacob KS, Everitt BS, Patel V, Weich S, Araya R, Lewis GH (1998). The comparison of latent variable models of non-psychotic morbidity in four culturally diverse populations. Psychol Med 28:145-152.
10. Kauhanen J, Hallikainen T, Tuomainen TP, Koulu M, Karvonen MK, Salonen JT, et al. (2000). Association between the function polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 24:135-139.
11. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
12. Lewis G, Pelosi AJ, Glover E, Wilkinson G, Stansfeld SA, Williams P, et al. (1988). The development of a computerised assessment for minor psychiatric disorder. Psychol Med 18:737-745.
13. Mynett-Johnson LA, Murphy VE, Claffey E, Sheilds DC, McKeon P (1998). Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8:221-225.
14. Nutt DJ, Forshall S, Bell C, Rich A, Stanford J, Nash J, et al. (1999). Mechansims of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 9(3):581-586.
15. Ohara K, Nagai M, Suzuki Y, Ochiai M, Ohara K (1998). No association between anxiety and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148.
16. Paperny DM, Aono JY, Lehman RM, Hammar SL, Risser J (1990). Computer-assisted detection and intervention in adolescent high-risk health behaviours. J Paediatr 116:456-462.
17. Papolos DF, Faedda GI, Veit S, Goldberg R, Morrow B, Kucherlapati R, et al. (1996). Bipolar spectrum disorders in patients diagnosed with velo-cardiofacial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 153:1541-1547.
18. Papolos DF, Veit S, Faedda GL, Saito T, Lauchman HM (1998). Ultra-ultra rapid cycling bi-polar disorder is associated with the low activity catechol-O-methyltransferase alleles. Mol Psychiatry 3:346-349.
19. Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. (2002). Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar patients with and without co morbid panic disorder. Am J Psychiatry 159:23-29
20. Rozen S, Skaletsky HJ. Primer 3 on the www for general users and for biologist programmers. In: Krawetz S, Misener S, editors. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, pp. 365-386.
21. Sterne JAC, Davey Smith G (2001). Sifting the evidence - what's wrong with significant tests? BMJ 322:226-231.
22. Tenhunen J, Salminen M, Lundström K, Kiviluoto T, Savolainen R, Ulmanen I (1994). Genomic organisation of the human catechol-o-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1059.
23. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J (1999). Association between the functional variant of the catechol-O- methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4:286-289.
24. Weinshilboum RM, Otterness DM, Szumlanski CL (1999). Methylation pharmacogentics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Ann Rev Pharmacol Toxicol 39:19-52.
25. Woo JM, Yoon KS, Yu BH (2002). Catechol-O-methyltransferase genetic polymorphism in panic disorder. Am J Psychiatry 159:1785-1787.
26. Xie T, Ho SL, Ramsden D (1999). Characterisation and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharm 56:31-38.
27. 158met genotypes affects μ-opioid neurotransmitter responses to a pain receptor. Science 299:1240-1243.